Clinical Trial Update: Envafolimab Combined With Chemoradiotherapy and Recombinant Human Endostatin for LA-NPC. [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating Envafolimab with chemoradiotherapy and recombinant human endostatin for locally advanced nasopharyngeal carcinoma; recruitment…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Carcinoma

Drugs mentioned

• Endostar (recombinant human endostatin)
• Envafolimab (envafolimab)

Snippet

Sponsor: Chongqing University Cancer Hospital | Conditions: Nasopharyngeal Carcinoma | Phase 2 | Status: RECRUITING